| Q3 2023 |
28 |
$238M |
+$24.9M |
-$62M |
-$37.1M |
PLRX, RPTX, CGEM, SLRN, LRMR
|
13F-HR |
11/13/2023, 05:03 PM |
| Q2 2023 |
31 |
$329M |
+$88.2M |
-$159M |
-$71M |
PLRX, SLRN, VECT, CGEM, RPTX
|
Restatement |
8/21/2023, 09:53 PM |
| Q1 2023 |
23 |
$377M |
+$21.2M |
-$18.6M |
+$2.53M |
RXDX, PLRX, VECT, CGEM, RPTX
|
13F-HR |
5/11/2023, 04:13 PM |
| Q4 2022 |
22 |
$375M |
+$19.4M |
-$85.6M |
-$66.2M |
RXDX, PLRX, VECT, RPTX, CGEM
|
13F-HR |
2/13/2023, 08:28 AM |
| Q3 2022 |
25 |
$372M |
+$37.6M |
-$17.9M |
+$19.7M |
RXDX, PLRX, CGEM, RPTX, VECT
|
13F-HR |
11/9/2022, 11:59 AM |
| Q2 2022 |
26 |
$262M |
+$48.7M |
-$218K |
+$48.5M |
RXDX, CGEM, RPTX, PLRX, VECT
|
13F-HR |
8/12/2022, 04:01 PM |
| Q1 2022 |
22 |
$235M |
+$37.4M |
-$7.39M |
+$30M |
RXDX, RPTX, CGEM, PLRX, VECT
|
13F-HR |
5/16/2022, 03:06 PM |
| Q4 2021 |
20 |
$301M |
+$33.4M |
-$45M |
-$11.6M |
RXDX, RPTX, CGEM, PLRX, LRMR
|
13F-HR |
2/11/2022, 10:42 AM |
| Q3 2021 |
19 |
$343M |
+$22.6M |
-$21.9M |
+$707K |
RXDX, RPTX, CGEM, PLRX, VECT
|
13F-HR |
11/15/2021, 01:16 PM |
| Q2 2021 |
18 |
$430M |
+$32.7M |
-$16.1M |
+$16.6M |
RPTX, RXDX, PLRX, CGEM, VECT
|
13F-HR |
8/11/2021, 04:59 PM |
| Q1 2021 |
21 |
$500M |
+$179M |
-$16.5M |
+$162M |
CGEM, PLRX, RPTX, RXDX, ORTX
|
13F-HR |
5/14/2021, 09:42 AM |
| Q4 2020 |
21 |
$355M |
+$56.4M |
-$13.4M |
+$43.1M |
RPTX, ONCR, PLRX, LRMR, KROS
|
13F-HR |
2/12/2021, 02:43 PM |
| Q3 2020 |
21 |
$281M |
+$58.9M |
-$7.23M |
+$51.7M |
RPTX, PLRX, INZY, LRMR, KROS
|
13F-HR |
11/12/2020, 02:01 PM |
| Q2 2020 |
18 |
$181M |
+$142M |
-$13.1M |
+$129M |
RPTX, AKUS, KROS, LRMR, ORTX
|
Restatement |
8/17/2020, 11:23 AM |
| Q1 2020 |
13 |
$42.4M |
+$3.19M |
-$73M |
-$69.8M |
ORTX, DTIL, LVGO, OVID, BPMC
|
13F-HR |
5/14/2020, 03:36 PM |
| Q4 2019 |
12 |
$133M |
+$1.88M |
-$5.24M |
-$3.36M |
LVGO, ORTX, DTIL, OVID, BPMC
|
13F-HR |
2/14/2020, 02:55 PM |
| Q3 2019 |
13 |
$103M |
|
|
|
LVGO, ORTX, DTIL, OVID, GBT
|
13F-HR |
11/12/2019, 12:21 PM |